Filing Details

Accession Number:
0001209191-16-152157
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-28 15:44:45
Reporting Period:
2016-11-23
Filing Date:
2016-11-28
Accepted Time:
2016-11-28 15:44:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434316 Fate Therapeutics Inc FATE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205903 H William Rastetter C/O Fate Therapeutics, Inc.;
3535 General Atomics Court, Suite 200
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-23 375,939 $2.66 459,272 No 4 P Indirect By The Investment 2002 Trust dated 11/11/02
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By The Investment 2002 Trust dated 11/11/02
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 118,360 Indirect By The Rastetter Family Trust, dated 09/02/10
Footnotes
  1. Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.
  2. These shares are owned of record by The Investment 2002 Trust, dated November 11, 2002 for which William H. Rastetter is the sole trustee and owner.
  3. These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.